U.S., April 8 -- ClinicalTrials.gov registry received information related to the study (NCT07516223) titled 'MRI-Assisted Guidance for Non-Essential Tissue Sampling' on March 31.
Brief Summary: The study aims to determine if a less painful and less invasive prostate biopsy approach is safe for certain men with a high risk of prostate cancer.
Currently, when a man has a suspicious MRI scan, standard medical guidelines recommend a "combined biopsy." This means the urologist performs a Targeted Biopsy (taking 3-5 tissue samples directly from the suspicious area seen on the MRI) followed immediately by a Systematic Biopsy (taking 12 additional samples blindly from the rest of the prostate). While this combined approach maximizes cancer detect...